Human newborn B cells mount an interferon-α/β receptor-dependent humoral response to respiratory syncytial virus

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 6, 2017, Pages 1997-2000.e4

  Jans, Jop ^a,b,c   Pettengill, Matthew ^b,c,d   Kim, Dhohyung ^e   van der Made, Cas ^a   de Groot, Ronald ^a   Henriet, Stefanie ^a   de Jonge, Marien I ^a   Ferwerda, Gerben ^a   Levy, Ofer ^b,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; CD69 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; ALPHA BETA INTERFERON RECEPTOR; CYTOKINE; VIRUS ANTIBODY;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMORAL IMMUNITY; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SUPERNATANT; UPREGULATION; VIRUS REPLICATION; BLOOD; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANTIBODIES, VIRAL; B-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN M; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; RECEPTOR, INTERFERON ALPHA-BETA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 85009373463     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.10.032     Document Type: Article

References (10)

1. Dowling, D.J., Levy, O., Ontogeny of early life immunity. Trends Immunol 35 (2014), 299–310.
2. Chiu, C., Openshaw, P.J., Antiviral B cell and T cell immunity in the lungs. Nat Immunol 16 (2015), 18–26.
3. Reed, J.L., Welliver, T.P., Sims, G.P., McKinney, L., Velozo, L., Avendano, L., et al. Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection. J Infect Dis 199 (2009), 1128–1138.
4. Stensballe, L.G., Ravn, H., Kristensen, K., Agerskov, K., Meakins, T., Aaby, P., et al. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol 123 (2009), 398–403.
5. Boukhvalova, M.S., Prince, G.A., Blanco, J.C., Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity. J Virol 81 (2007), 9443–9450.
6. Tangye, S.G., To B1 or not to B1: that really is still the question!. Blood 121 (2013), 5109–5110.
7. Savage, H.P., Baumgarth, N., Characteristics of natural antibody-secreting cells. Ann N Y Acad Sci 1362 (2015), 132–142.
8. Zorc, J.J., Hall, C.B., Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 125 (2010), 342–349.
9. Norrby-Teglund, A., Haque, K.N., Hammarstrom, L., Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med 260 (2006), 509–516.
10. Vissers, M., Schreurs, I., Jans, J., Heldens, J., de Groot, R., de Jonge, M.I., et al. Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells. Cytokine 76 (2015), 458–464.